Marketing-authorisation holder · United States
Nextwave Pharms
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| QUILLICHEW ER20mg | 30mg | 40mg · Tablet, extended release, chewable | Methylphenidate | United States | Marketed | 2015 |
| QUILLIVANT XR5mg/ml · For suspension, extended release | Methylphenidate | United States | Marketed | 2012 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.